Literature DB >> 24969657

Differential expression of IL-33 and HMGB1 in the lungs of stable cystic fibrosis patients.

Kerstin Tiringer1, Angela Treis2, Stefan Kanolzer1, Carina Witt1, Bahil Ghanim3, Saskia Gruber1, Klara Schmidthaler1, Sabine Renner1, Eleonora Dehlink1, Edith Nachbaur1, Thomas Frischer1, Walter Klepetko3, Cezmi A Akdis2, Zsolt Szépfalusi1, Thomas Eiwegger4.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 24969657     DOI： 10.1183/09031936.00046614

Source DB:  PubMed          Journal:  Eur Respir J        ISSN： 0903-1936            Impact factor:   16.671


× No keyword cloud information.
  14 in total

1.  High mobility group box 1 protein in bronchoalveolar lavage fluid and correlation with other inflammatory markers in pulmonary diseases.

Authors:  Magda Suchankova; Vladimira Durmanova; Elena Tibenska; Eva Tedlova; Ivan Majer; Helena Novosadova; Juraj Demian; Miroslav Tedla; Maria Bucova
Journal:  Sarcoidosis Vasc Diffuse Lung Dis       Date:  2018-04-28       Impact factor: 0.670

Review 2.  The Role of HMGB1, a Nuclear Damage-Associated Molecular Pattern Molecule, in the Pathogenesis of Lung Diseases.

Authors:  Mao Wang; Alex Gauthier; LeeAnne Daley; Katelyn Dial; Jiaqi Wu; Joanna Woo; Mosi Lin; Charles Ashby; Lin L Mantell
Journal:  Antioxid Redox Signal       Date:  2019-07-11       Impact factor: 8.401

Review 3.  Group 2 Innate Lymphoid Cells in Human Respiratory Disorders.

Authors:  Esmee K van der Ploeg; Ana Carreras Mascaro; Danny Huylebroeck; Rudi W Hendriks; Ralph Stadhouders
Journal:  J Innate Immun       Date:  2019-02-06       Impact factor: 7.349

4.  The Induction of IL-33 in the Sinus Epithelium and Its Influence on T-Helper Cell Responses.

Authors:  Michael B Soyka; David Holzmann; Tomasz M Basinski; Marcin Wawrzyniak; Christina Bannert; Simone Bürgler; Tunc Akkoc; Angela Treis; Beate Rückert; Mübeccel Akdis; Cezmi A Akdis; Thomas Eiwegger
Journal:  PLoS One       Date:  2015-05-01       Impact factor: 3.240

Review 5.  The IL-1 cytokine family and its role in inflammation and fibrosis in the lung.

Authors:  L A Borthwick
Journal:  Semin Immunopathol       Date:  2016-03-21       Impact factor: 9.623

Review 6.  Epithelial Anion Transport as Modulator of Chemokine Signaling.

Authors:  Andrea Schnúr; Péter Hegyi; Simon Rousseau; Gergely L Lukacs; Guido Veit
Journal:  Mediators Inflamm       Date:  2016-06-12       Impact factor: 4.711

7.  A mast cell-ILC2-Th9 pathway promotes lung inflammation in cystic fibrosis.

Authors:  Silvia Moretti; Giorgia Renga; Vasilis Oikonomou; Claudia Galosi; Marilena Pariano; Rossana G Iannitti; Monica Borghi; Matteo Puccetti; Marco De Zuani; Carlo E Pucillo; Giuseppe Paolicelli; Teresa Zelante; Jean-Christophe Renauld; Oxana Bereshchenko; Paolo Sportoletti; Vincenzina Lucidi; Maria Chiara Russo; Carla Colombo; Ersilia Fiscarelli; Cornelia Lass-Flörl; Fabio Majo; Gabriella Ricciotti; Helmut Ellemunter; Luigi Ratclif; Vincenzo Nicola Talesa; Valerio Napolioni; Luigina Romani
Journal:  Nat Commun       Date:  2017-01-16       Impact factor: 14.919

8.  HMGB1 induces lung fibroblast to myofibroblast differentiation through NF‑κB‑mediated TGF‑β1 release.

Authors:  Qiong Wang; Jun Wang; Junfang Wang; Shanchao Hong; Feifei Han; Jingyu Chen; Guoqian Chen
Journal:  Mol Med Rep       Date:  2017-03-23       Impact factor: 2.952

Review 9.  Oxidative and endoplasmic reticulum stress in respiratory disease.

Authors:  Alice C-H Chen; Lucy Burr; Michael A McGuckin
Journal:  Clin Transl Immunology       Date:  2018-06-13

10.  The TAK1→IKKβ→TPL2→MKK1/MKK2 Signaling Cascade Regulates IL-33 Expression in Cystic Fibrosis Airway Epithelial Cells Following Infection by Pseudomonas aeruginosa.

Authors:  Raquel Farias; Simon Rousseau
Journal:  Front Cell Dev Biol       Date:  2016-01-11
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.